0       0


SN5-40: ASTCT/AABB Joint Session on Adoptive Immunotherapy


Oct 20, 2019 4:00pm ‐ Oct 20, 2019 5:30pm

Description

Joint ASBMT/AABB Session on Adoptive Immunotherapy 

This session will explore the adoptive immunotherapy space including overviews of our regulatory, financial advocacy and toxicity reporting efforts.

Learning Objectives:

  • Describe regulatory reporting in adoptive immunotherapy.
  • Review financial advocacy in adoptive immunotherapy.
  • Define toxicity reporting.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content